Bimagrumab leads to increased muscle mass and muscle function, and may also further help with weight loss
The most frequently reported adverse effects include: These side effects often occur during dose escalation and tend to diminish over time
Vijiaratnam N, Girges C, Auld G, McComish R, King A, Skene SS, Hibbert S, Wong A, Melander S, Gibson R, Matthews H, Dickson J, Carroll C, Patrick A, Inches J, Silverdale M, Blackledge B, Whiston J, Hu M, Welch J et al (2025) Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinsons disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial
Monitoring, protein targets, and movement habits influence the final pace
Keeping it in this setting assists in averting the deterioration of the medication